FDA Warns of Dangerous Testosterone Risks for Men, NBC News Reports
NBC Nightly News reports that “[t]estosterone treatment is a growing multibillion-dollar business, but it presents the risk of life-threatening blood clots.” In the news segment, the NBC reporter comments: “In 2013, doctors wrote 7.5 million prescriptions for testosterone, up from about 4 million in 2009. While treatment for abnormally low testosterone levels is warranted in some men, it’s not without risk. And now a new warning from the Food and Drug Administration about increased risk of life-threatening blood clots called deep vein thrombosis…. Unlike hormone replacement therapy that’s been used by women treating menopause, there isn’t enough long-term data on the real risks.”
The current $2 Billion testosterone market is expected to grow to $5 Billion by 2017. These monetary figures are partly attributed to the aggressive marketing tactics employed by the testosterone drug manufacturers. Manufacturers of these testosterone products are now facing a multitude of lawsuits after the Judicial Panel on Multidistrict Litigation (JPML) entered an order consolidating all cases filed in federal court over alleged injuries involving testosterone products into a Multidistrict Litigation (MDL 2545) pending before The Honorable Judge Matthew F. Kennelly in the Northern District of Illinois.
Schlichter, Bogard & Denton are leaders in the national Low-T Multidistrict Litigation. In early July, Judge Kennelly appointed Kristine Kraft of Schlichter, Bogard & Denton to the Plaintiffs’ Steering Committee, which will oversee and manage the growing number of cases pending against the Low-T manufacturers.
If you or a loved one has suffered injuries after using testosterone products, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.
The choice of a lawyer is an important decision and should not be based solely on advertisements.